Insider Transactions in Q1 2023 at Mi Nk Therapeutics, Inc. (INKT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
6,699
+13.55%
|
$13,398
$2.09 P/Share
|
|
Mar 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
8,553
+2.71%
|
$17,106
$2.09 P/Share
|
|
Mar 01
2023
|
John Baldoni |
BUY
Grant, award, or other acquisition
|
Direct |
6,878
+22.75%
|
$13,756
$2.09 P/Share
|
|
Mar 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
7,357
+22.75%
|
$14,714
$2.09 P/Share
|
|
Mar 01
2023
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
8,493
+22.75%
|
$16,986
$2.09 P/Share
|
|
Jan 09
2023
|
Marcus Antonius Van Dijk Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,265
-47.0%
|
$48,530
$2.32 P/Share
|
|
Jan 09
2023
|
Marcus Antonius Van Dijk Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,628
+50.0%
|
$103,256
$2.32 P/Share
|
|
Jan 09
2023
|
Jennifer Buell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
171,990
+31.12%
|
$343,980
$2.32 P/Share
|